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Copyright © 2009 JCBN Summary The objective of the present study was to assess the ascorbic acid (AA) levels in
seminal plasma of the fertile and infertile men and to investigate its relationship with sperm
count, motility and normal morphology. Semen samples were provided by fertile [smoker
(n = 25), nonsmoker (n = 21)] and infertile men [smoker (n = 23), nonsmoker (n =3 2 ) ] .  A
simplified method of reverse phase high performance liquid chromatography (RP-HPLC)
procedure using UV detection was applied for the determination of seminal AA. Fertile sub-
jects, smoker or not, demonstrated significantly higher seminal AA levels than any infertile
group (p<0.01). Nonsmokers had high, but no significant, mean AA levels in their seminal
plasma compared with smokers. Seminal AA in fertile and infertile (smokers or nonsmokers)
males correlated significantly with the percentage of spermatozoa with normal morphology
(p<0.01). Seminal AA decreased significantly in infertile men. Decrease of seminal plasma AA
is a risk factor for low normal morphology of spermatozoa and idiopathic male infertility.
Measurement of seminal AA in the seminal plasma of males with a history of subfertility or
idiopathic infertility is necessary and can be helpful in fertility assessment.
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Introduction
Oxidative stress induced by reactive oxygen species
(ROS) has recently been proposed as one of the major causes
for human male infertility [1, 2]. It occurs as a consequence
of imbalance between the production of ROS and the avail-
able antioxidants defense against them [3]. Excessive ROS
can be produced by immature sperm and leukocyte cells [4].
It can impair normal sperm function by peroxidation of
unsaturated fatty acids in membrane of spermatozoa and by
DNA fragmentation [4, 5].
In order to counteract the toxic effects of ROS, human
seminal plasma with low molecular weight antioxidants
able to act as a free radical scavenger and hence it protects
spermatozoa against free radicals [2,  6–9]. This defense
mechanism compensates the loss of sperm cytoplasmic
enzymes when the cytoplasm is extruded during maturation
[10,  11]. Among low molecular weight antioxidants, the
outstanding role of ascorbic acid has received particular
attention. The higher concentrations of ascorbic acid in the
epididymal fluid and seminal plasma compared with blood
plasma have been reported previously for several species
[12, 13]. High concentrations of ascorbic acid in seminal
plasma may protect sperm from ROS and maintain the
genetic integrity of sperm cells by preventing oxidative
damage to DNA [14–16]. Generally, ascorbic acid is thought
to act as an excellent reducing agent since it is also able to
reduce catalytically active transition metal ions and free
radicals [17]. In this process, ascorbic acid oxidizes and
become a radical itself (semidehydroascorbate radical,
ascorbate free radical, AFR) [18]. Unlike other free radicals,
AFR is relatively unreactive and it can decay through
disproportionation to ascorbic acid and dehydroascorbicHuman Seminal Plasma Ascorbic Acid and Sperm Quality
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acid (DHAA), and consequently it can interrupt the propaga-
tion of free radical chain reactions [18]. Hence, seminal
plasma is extremely sensitive to a decrease in body levels of
ascorbic acid [19]. There are conflicting reports on the effect
of seminal ascorbic acid (AA) on the parameters of sperm
quality. In the present study, it was hypothesized that major
changes in the level of seminal plasma AA is related to low
quality of sperm and poor fertilizing capacity. This study
focused primarily on AA levels in the seminal plasma of
fertile and infertile subjects (smokers and nonsmokers). The
association of AA with sperm quality in the seminal plasma
of all groups was evaluated.
Numerous principles of assays such as spectrophoto-
metric determination and enzymatic method with ascorbic
acid oxidase have been described for ascorbic acid detection
in biological fluids and tissues [20,  21]. Rapid, reliable
and sensitive AA determinations have been performed by
high performance chromatography. High-performance liquid
chromatography is the most common method for identifica-
tion and quantification of antioxidant vitamins in biological
fluids [18]. Recently several HPLC methods such as ion
exchange and ion paired reverse phase HPLC, mostly
coupled with electrochemical detection (ECD), have been
presented for the determination of vitamin C in serum or
seminal plasma [21–25]. In the present research we applied
a simple RP-HPLC method, coupled with UV detection, for
seminal AA determination by using a simple pretreatment
procedure.
Materials and Methods
Semen populations and collections
One hundred and-one semen samples were collected from
fertile nonsmokers (n = 21), fertile smokers (n =2 5 ) ,
infertile nonsmokers (n = 32) and infertile smokers (n = 23)
referred to the Fatemeh Zahra in-vitro fertilization (IVF)
center in Babol, Iran. Semen samples were obtained by
masturbation into a sterile container after sexual abstinence
for 2–3 days. Before semen analysis, a questionnaire was
distributed to obtain information on smoking habits; alcohol
use; use or abuse of other substances and drugs; and a
history of orchitis, testicular trauma, sexually transmitted
disease, varicocele, surgery for inguinal hernia, and
cryptorchism. Fertile and infertile patients who smoked
cigarettes regularly or who were nonsmokers (never pre-
viously smoked) were included in the study.
After collection, semen specimens were allowed to liquefy
at room temperature for 30 min and used for analysis. On
microscopic examination, sperm count, percentage of motile
sperm, and sperm with normal morphology were objectively
evaluated. Sperm count and percentage of motile sperm
were evaluated according to standards set by the World
Health Organization (WHO) [26]. Sperm morphology was
evaluated according to Kruger’s criteria [27].
Measurement of ascorbic acid in seminal plasma
Chemical and equipment—Ascorbic acid stock solutions
were prepared from L (+) ascorbic acid (Merck, Darmstadt,
Germany). The HPLC grade methanol and acetic acid
glacial were purchased from Fluka (Buchs, Switzerland).
Deionized water obtained with a Milli-Q purification system
(Millipore, Bedford, MA), and filtered through 0.45 μm
Millipore solvent filter, was used for all reagent and standard
solutions. A stock solution of Vitamin C was prepared at
5 mg/lit in methanol. The stock solutions were further
diluted with methanol to give a series of working standards.
Pure methanol was stored at −20°C and used to initiate
protein precipitation in seminal plasma.
Samples preparation for HPLC—Semen sample was centri-
fuged at 4000 g for 5 min. A 100 μl aliquot of supernatant
was admixed with 900 μl of cold methanol (100%). All
samples were vortexed for 20 seconds and cold-centrifuged
at 10000 g for 3 min. Each supernatant was kept at −20°C
until a 20 μl aliquot was injected onto the HPLC system.
HPLC system
The HPLC system consisted of a model 1525 pump,
Rheodyne 7725i injector equipped with 20 μL sample loop,
Spherisorb C18 column (150 × 4.6 mm, 5 μm particle size)
and model 2487 UV detector all from Waters (Waters
Assoc., Milford, MA). For data acquisition, Waters Breeze
software was used. The experiments were performed in
isocratic mode in different mobile phase composition. The
mobile phase consisted of 2.5% acetic acid glacial and 80%
methanol in ddH2O, and then it was filtered through a
0.45 μm filter under vacuum and degassed before use. The
flow rate was maintained at 1 ml/min and spectrophoto-
metric detection at 254 nm was employed. The isocratic
chromatographic system was conditioned by passing the
eluent through the column until a stable base line was
observed. Then, repeatable retention times were obtained
for three subsequent injections.
Statistical analysis
An independent t test was considered to compare the
scores of each of the measures and some of the parameters
data between the two groups. The ANOVA model was
utilized for statistical analyses of elements concentration
between all groups. The Pearson correlation and linear
regression model was used for utilize and examine the rela-
tion between seminal AA and sperm parameters quality. A
p value<0.05 was considered statistically significant. Data
were analyzed using SPSS, version 11.5 (FAQs).A.H. Colagar and E.T. Marzony
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Results
The mean values of examined sperm parameters in the
fertile and infertile men (smokers and nonsmokers) are
shown in Table 1. Sperm count, motility and normal
morphology in fertile group (smokers or nonsmokers) were
significantly higher than those in infertile group. A trend
toward a higher quality of sperm was seen for nonsmokers
compared with smokers (Table 1).
The concentrations of seminal ascorbic acid in both
groups were measured by RP-HPLC method. Peak identity
was proven both by the correspondence of standard solution
and sample retention times (<5 min), and the coelution of
added and endogenous AA. A typical chromatogram of
seminal AA is shown in Fig. 1. Under the conditions
employed, all peaks of interest were well resolved from
interfering peaks, and eluted in <5 min. Mean concentrations
of ascorbic acid in the seminal plasma of all samples can be
seen in Table 1. Total seminal plasma ascorbic acid content
ranged from 206.7 to 678.2 μmol/l in all individuals. Fertile
groups (smokers or nonsmokers) demonstrated significantly
higher AA levels in their seminal plasma than any infertile
groups (p<0.01). A trend was observed for a lower mean
AA level in seminal plasma of smokers compared with
nonsmokers. Fertile nonsmokers had significantly high
levels of AA in their seminal than infertile nonsmokers
(p<0.05), moreover, fertile smokers had significantly high
levels of AA in their seminal plasma compared with infertile
smokers (p<0.01).
Fig. 2 shows the correlation between ascorbic acid and
the percentage of spermatozoa with normal morphology.
The ascorbic acid in seminal plasma was positively corre-
lated to the spermatozoa with normal morphology (r2 =0 . 7 9 ,
p<0.01).
Discussion
Ascorbic acid as the principle antioxidant in seminal
plasma of fertile men, can contribute up to 65% of its total
Table 1. Comparison of sperm parameters quality and ascorbic acid in the fertile and infertile smoker-nonsmoker men
Values are mean ± SD. *p<0.001 by using 1-way ANOVA followed by post hoc Newman-Keuls test when values of infertile nonsmokers
are compared with fertile nonsmokers. **p<0.05 by using 1-way ANOVA followed by post hoc Newman-Keuls test when values of
infertile nonsmokers are compared with fertile nonsmokers. †p<0.01 by using 1-way ANOVA followed by post hoc Newman-Keuls test
when values of infertile nonsmokers are compared with fertile nonsmokers. ***p<0.001 by using 1-way ANOVA followed by post hoc
Newman-Keuls test when values of infertile smokers are compared with fertile smokers. ††p<0.01 by using 1-way ANOVA followed by
post hoc Newman-Keuls test when values of infertile smokers are compared with fertile smokers.
Variable
Nonsmoker men (n = 53) Smoker men (n = 48)
Fertile (n = 21) Infertile (n = 32) Fertile (n = 25) Infertile (n =2 3 )
Age (years) 31.38 ± 4.36 29.55 ± 4.46 29.7 ± 5.14 31.37 ± 7.4
Volume (ml) 4.14 ± 1.36 3.85 ± 1.53 4.35 ± 1.47 3 ± 1.53
Sperm count (×106 ml) 80 ± 29.63 36.90 ± 29.91* 71 ± 28.81 31.81 ± 21***
Total sperm (×106) 330.71 ± 145.60 137.11 ± 124.33* 310.5 ± 150.63 60.63 ± 47.04***
Motility (%) 73.1 ± 16.3 50.06 ± 29.69† 72 ± 16.73 43.75 ± 32.99***
Normal morphology (%) 
(by Kruger criteria)
14.93 ± 3.63 5.96 ± 4.36* 12.9 ± 4.78 3.75 ± 2.11***
Ascorbic acid (μmol/l) 448.71 ± 98.13 412.81 ± 114.51** 440.04 ± 103.31 383.13 ± 94.89††
Fig. 1. Representative chromatograms from ascorbic acid (AA)
in seminal plasma. Samples were prepared as described
in materials and methods. The mobile phase consisted of
2.5% acetic acid glacial and 80% methanol in ddH2O;
flow rate: 1 ml/min and spectrophotometric detection
at 254 nm; column: a Spherisorb C18 column
(150 × 4.6 mm, 5 μm particle size).Human Seminal Plasma Ascorbic Acid and Sperm Quality
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chain breaking antioxidant capacity [3]. This system
scavenges harmful ROS before they react with other impor-
tance molecules and terminates the subsequent chain reac-
tion [28]. There have been conflicting reports on the effect
of seminal AA on sperm quality [29–31]. Some studies
indicated that there is no significant difference between AA
content in the fertile and infertile men [32], but others found
a significant difference between them [12, 33–35], which
was in agreement with our study. Some authors have
reported a positive relationship between seminal AA and
quality of sperm in the seminal plasma of fertile and infertile
men [35,  36], whereas others reported no significant
difference [37–41]. Thiele et al. [12] observed that infertile
patients had significantly lower ascorbic acid in their seminal
plasma than fertile men, and ascorbic acid was positively
correlated with the percentage of sperm with normal mor-
phology. In our study ascorbic acid levels in seminal plasma
of all subjects ranged from 206.7 to 678.2 µmol/l. Our results
were agree with the findings of other studies [16, 33, 42]. In
this investigation, fertile men had significantly high levels of
ascorbic acid in their seminal plasma than infertile groups,
and ascorbic acid was positively correlated with the
percentage of sperm with normal morphology. In other
report, Mostafa et al. [32] analyzed differences in ascorbic
acid levels in the seminal plasma of smokers and non-
smokers. They found a significant decrease in the mean
seminal plasma ascorbic acid levels in smokers versus non-
smokers. In addition, seminal plasma ascorbic acid levels
were positively correlated with the sperm concentration,
motility and sperm with normal morphology [32]. In our
study, a trend was observed for a lower mean AA level in
seminal plasma of smokers compared with nonsmokers.
Our results suggested that smokers are susceptible to AA
deficiency in their seminal fluid. On the other hand,
decreased of seminal plasma ascorbic acid can not be a
main effect of cigarette smoking on sperm parameters
quality in smokers, which merits further study.
The mechanism by which ascorbic acid in the seminal
plasma of infertile patients (smokers or nonsmokers), is
depleted has not been fully elucidated. Evidence suggests
that one consequence of ascorbic acid deficiency can be an
increase in oxidative damage induced by ROS [43]. Recent
studies have indicated that high levels of ROS are detected
in the semen of 25 to 45% of infertile men [5, 43]. A small
amount of ROS is necessary for sperm to acquire fertilizing
capabilities [2], but it appears that high levels of seminal
ROS may decrease the effective concentration of seminal
ascorbic acid. Increased ROS in the seminal plasma of
infertile men may decrease the effective concentration of
ascorbic acid, increasing the harmful effects of ROS to
sperm cells that are associated with abnormal sperm para-
meters [18, 44]. Several studies supported this hypothesis,
noting that supplementation of ascorbic acid cause signifi-
cant reduction in ROS concentration [45], sperm membrane
lipid peroxidation [46] and sperm DNA oxidation [47]. In
addition, ascorbic acid treatment had a positive effect on
sperm quality and supplementation of biologic ascorbic acid
was an effective method for the treatment of infertile males
with poor sperm quality [14, 45–47]. Men who smoke inhale
a host of toxic substances such as free radicals that can be
absorbed, so a causal relationship is suspected. Recently
studies have shown that cigarette smoking lead to increased
seminal ROS by several mechanisms: (i) cigarette smoking
itself contains high levels of ROS, (ii) smoking metabolites
may induce an inflammatory reaction in the male genital
tract with a subsequent release of chemical mediation of
inflammation that can recruit and active leukocytes. Acti-
vated leukocytes can generation high levels of ROS in
semen and (iii) toxic metabolites of cigarette smoke may
impair spermatogenesis, resulting in the production of
abnormal spermatozoa, which is an important source of
ROS and oxidative stress [48]. High levels of ROS induced
by smoking may overwhelm the antioxidant strategies
(especially ascorbic acid effective concentration), resulting
in oxidative stress which associated with low quality of
sperm in smokers [48]. Dawson et al. [49] showed also
the beneficial effect of ascorbic acid oral administration on
sperm concentration, morphology and viability in smokers.
Therefore, infertile men, smoker or nonsmoker, are parti-
cularly susceptible to seminal ascorbic acid deficiency.
Hence, the ascorbic acid supplementation may improve the
sperm parameters quality, however, antioxidant therapy in
men can be improved sperm quality is particularly dose
dependent [50].
In conclusion, our findings suggested that idiopathic
infertile men have significantly low levels of ascorbic acid
Fig. 2. Correlation between the seminal plasma AA content
with sperm with normal morphology. Seminal plasma
AA was positively correlated with sperm with normal
morphology (r2 = 0.0796, p<0.01). The Pearson correla-
tion test was used to analyze and examine the relation-
ship between AA with sperm parameters.A.H. Colagar and E.T. Marzony
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in their seminal plasma than fertile men. Association of
seminal ascorbic acid with normal morphology of sperm
may indicate that the decrease in seminal ascorbic acid
content can be a risk factor for sperm abnormality and idio-
pathic male infertility. In the present study, smokers were
susceptible to seminal ascorbic acid deficiency, compared
with nonsmokers. Therefore, the analysis of ascorbic acid in
seminal plasma of idiopathic infertile patients, smokers or
nonsmokers, may afford valuable evidence in exploring the
mechanism of male infertility.
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